EUIPO trademark

RYSBEVI

RegisteredEUIPOWord markClass 5

"RYSBEVI" is a word mark owned by Sarepta Therapeutics, Inc., filed at the EUIPO on June 25, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Sarepta Therapeutics, Inc. portfolioGet this data via the API
Official EUIPO record
RYSBEVI
Word mark as filed with the EUIPO
Status
Registered
Since November 18, 2025
Filed
June 25, 2025
Registered
November 16, 2025
Expires
June 25, 2035
Application no.
019207630
Registration no.
019207630
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns RYSBEVI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Sarepta Therapeutics, Inc.

SRPT

215 trademarks in the portfolioView company

Representative

Thomas Tresper

Goods and services

What the mark covers

The products and services RYSBEVI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceuticals, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2025/218 Section B.1
  2. Bulletin 2025/147 Section A.1
FAQ

About RYSBEVI

Who owns the trademark "RYSBEVI"?

The EUIPO trademark "RYSBEVI" (application 019207630) is owned by Sarepta Therapeutics, Inc.

What is the status of "RYSBEVI"?

Its status at the EUIPO is: registered.

When was "RYSBEVI" registered?

It was registered on November 16, 2025 and is due to expire on June 25, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RYSBEVI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d47c3-a9bf-763d-9c8b-a14d448d61ff
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d47c3-a9bf-763d-9c8b-a14d448d61ff",
  "object": "trademark",
  "mark_text": "RYSBEVI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019207630",
  "filing_date": "2025-06-25",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Sarepta Therapeutics, Inc.",
      "entity_id": "ent_019ebbb7-51a3-7732-89ae-4e7311f24a9c"
    }
  ]
}